.png)
The CareVoice is a technology company.
Health and Wellness solutions enable increased long-term customer value through health engagement.
The CareVoice has raised $10.0M across 1 funding round.
The CareVoice has raised $10.0M in total across 1 funding round.
The CareVoice is a leading insurtech company that builds CareVoiceOS, a SaaS platform and healthcare operating system for health and life insurers. It enables personalized customer health journeys—from symptom triage and doctor searches to policy management, wellness services, and claims automation—while optimizing insurer workflows to boost revenues, retention, and cost efficiency.[1][2][4][5] Serving over 35 insurance clients across 12+ countries (primarily Asia, with expansion to Middle East and Latin America), it solves insurers' challenges in delivering customer-centric health engagement amid complex regulations and execution hurdles, achieving metrics like 7-15% improvement in policy persistency.[3][4][6]
The platform acts as an "Embedded Health Orchestrator," integrating a mobile app for policyholders with enterprise tools for insurers, partnering with 70+ global and local tech providers for localized experiences. Backed by investors like SOSV, Apis Partners, and others, it raised a Series A in 2019 and nearly $10M in Series B in 2024 to fuel global growth and innovation.[1][3][6]
Founded in 2014 in Hong Kong (with early operations in Shanghai, China), The CareVoice emerged from founders with deep healthcare and enterprise software expertise.[3][5] Sebastien Gaudin (CEO & Co-Founder), a healthcare entrepreneur with pharma management background and prior founder experience (Master's from ESSEC Business School), led the vision alongside Jan Velich (CBO & Co-Founder), an international healthcare executive skilled in strategy execution, and Neil Liang.[3]
The idea pivoted from a consumer app tackling mistrust in medical services—offering ratings, doctor recommendations, appointments, and peer consultations—to CareVoiceOS, an API-based infrastructure solving insurers' needs for bespoke customer journeys.[1][7] Early traction came via partnerships like Ping An accelerator and Axa Taiping, focusing on B2B with insurers/employers to drive preventive care, retention, and lower costs without heavy consumer marketing.[1][7] This evolution positioned it as a key Asian insurtech player.[5]
The CareVoice rides the insurtech and embedded insurance wave, where digital platforms transform fragmented health insurance into seamless, preventive ecosystems amid rising demand for personalized wellness post-pandemic.[2][5] Timing aligns with insurers' digital maturity push—facing execution gaps in customer programs—fueled by AI, APIs, and regulatory shifts favoring localized health tech in Asia/Middle East/Latin America.[1][4]
Market forces like customer retention costs (3x acquisition) and preventive care trends favor its B2B model, reducing insurer overheads while boosting engagement via integrated services.[7] It influences the ecosystem by setting standards for "open health platforms," enabling 10M+ users and insurer innovation, as seen in AXA/Prudential integrations.[1][4]
The CareVoice is poised for global dominance as the #1 open health platform, targeting 15+ countries and 10M users by leveraging Series B funds for product innovation (e.g., next-gen CareVoiceOS) and hires like Chief Product Officer Shane Di.[1][6] Trends like AI-driven personalization, embedded health in super-apps, and emerging-market growth will propel it, especially as insurers prioritize retention amid economic pressures.
Its influence may evolve from Asian insurtech leader to worldwide orchestrator, empowering bespoke journeys that blend insurance with holistic care—ultimately making health insurance as intuitive as the platforms policyholders already love.[1][2][4]
The CareVoice has raised $10.0M in total across 1 funding round.
The CareVoice's investors include DNA Capital, Precursor Ventures.
The CareVoice has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in August 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2019 | $10.0M Series A | DNA Capital, Precursor Ventures |